Question

A physical examination was used to screen for breast cancer in 2,500 women with biopsy-proven adenocarcinoma...

A physical examination was used to screen for breast cancer in 2,500 women with biopsy-proven adenocarcinoma of the breast and in 5,000 age- and race-matched control women. The results of the physical examination were positive (i.e., a mass was palpated) in 1,800 cases and in 800 control women.

If the disease prevalence INCREASES , what effect, if any, would this have on i) sensitivity, ii) specificity, iii) positive predictive value, and iv) negative predictive value?

Homework Answers

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Suppose that a screening test for breast cancer has 95% sensitivity and 90% specificity. Assume 1%...
Suppose that a screening test for breast cancer has 95% sensitivity and 90% specificity. Assume 1% of the population being screened truly has breast cancer. a. If you really do have breast cancer, what is the probability that the test says you do? b. If you really do not have breast cancer, what is the probability that the test says you do? c. The screening test is applied to a total of 15 people; 5 who really do have cancer...
Question 1. The main purpose of screening is to identify symptomatic disease using tests, exams, or...
Question 1. The main purpose of screening is to identify symptomatic disease using tests, exams, or other procedures. True False Question 2. The detectable pre-clinical phase of a disease starts when the disease can be identified by a screening test and ends when the disease produces symptoms. True False Question 3 .Diseases that are appropriate for screening… a. Have serious consequences b. Have a treatment that is more effective at an earlier stage c. Have a detectable preclinical phase that...
A medical research team identified a new peptide growth factor, breast carcinoma promoting factor (BCPF) in...
A medical research team identified a new peptide growth factor, breast carcinoma promoting factor (BCPF) in explant cultures of breast tumors. A pilot study revealed that plasma levels of BCPF were elevated in confirmed breast cancer patients. The investigators conducted a clinical trial to determine criterion of 150 units /L. The investigators found out that the BCPF had a sensitivity of 95% and specificity of 85%. A health researcher now wishes to assess the predictive ability of the BCPF test...